Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 715.23 Million

CAGR (2026-2031)

4.75%

Fastest Growing Segment

Liquid

Largest Market

North America

Market Size (2031)

USD 944.87 Million

Market Overview

The Global Niacinamide Market will grow from USD 715.23 Million in 2025 to USD 944.87 Million by 2031 at a 4.75% CAGR. Niacinamide, also known as nicotinamide, is a prominent water-soluble form of Vitamin B3 widely utilized across the pharmaceutical, cosmeceutical, and animal nutrition sectors. The market is fundamentally supported by the escalating global demand for active skincare ingredients that promote barrier repair and anti-aging, alongside the critical requirement for essential metabolic supplements in livestock feed. This robust engagement in the personal care sector is substantiated by recent industry figures. According to Cosmetics Europe, in 2024, the European cosmetics and personal care market achieved a retail sales value of €104 billion, with the skin care category alone contributing €30.1 billion to this total.

Despite this strong commercial momentum, the market encounters a significant challenge regarding the price volatility of key raw materials. Fluctuations in the cost and availability of essential precursors, such as 3-cyanopyridine, can disrupt manufacturing stability and squeeze profit margins for producers. This supply chain unpredictability complicates long-term planning and may impede the consistent expansion of the global niacinamide supply network.

Key Market Drivers

Rising consumer demand for anti-aging and hyperpigmentation treatments constitutes a primary commercial engine for the niacinamide market. This ingredient is increasingly favored for its clinical ability to improve skin barrier function and reduce discoloration, leading to its widespread presence in dermatological formulations. This trend is evident in the financial performance of major sector players focusing on active cosmetics. According to L'Oréal, February 2024, in the '2023 Annual Report', their Dermatological Beauty division achieved a like-for-like sales growth of 28.4%, reflecting the intense consumer appetite for efficacy-driven skincare products. Such substantial expansion in the dermocosmetics sector directly amplifies the procurement of high-purity niacinamide for premium serum and cream formulations. To further illustrate the vitality of the broader personal care environment, according to Beiersdorf, February 2024, in the 'Annual Report 2023', their Consumer Business Segment recorded organic sales growth of 12.5%, indicating a sustained global uptake of finished goods that utilize these active ingredients.

Concurrently, the market is heavily influenced by the increasing incorporation of niacinamide in animal nutrition and livestock feed additives. Beyond its cosmetic applications, Vitamin B3 is essential for metabolic health in poultry, swine, and dairy cattle, driving consistent industrial-volume orders that stabilize the supply chain. This segment relies on the continuous production of compound feed to support global protein consumption requirements. According to Alltech, February 2024, in the '2024 Agri-Food Outlook', global feed production volumes reached 1.29 billion metric tons, underscoring the vast industrial requirement for essential additives. This sheer scale of feed manufacturing necessitates a steady, high-volume inflow of niacinamide to prevent deficiency diseases and ensure optimal growth rates in livestock, thereby creating a solid industrial foundation for the global market that balances the volatility of the cosmetic sector.

Download Free Sample Report

Key Market Challenges

The price volatility of key raw materials, particularly essential precursors such as 3-cyanopyridine, constitutes a substantial challenge hindering the growth of the Global Niacinamide Market. These sharp cost fluctuations create an unstable financial environment for manufacturers, directly compressing profit margins and making long-term capital allocation difficult. When the prices of these chemical intermediates rise unexpectedly, producers incur higher operational expenditures that cannot easily be passed down to price-sensitive clients in the pharmaceutical and cosmeceutical sectors, thereby reducing the capital available for market expansion and innovation.

This instability is further compounded by the unpredictability of the global supply chain, which subjects the market to erratic trade flows and tariff uncertainties. Such disruptions force companies to prioritize short-term inventory management over strategic growth initiatives. According to the China Chamber of Commerce for Import & Export of Medicines & Health Products, in 2024, the export value of China's health foods, a key category encompassing niacinamide products, reached $4.28 billion amidst these complex trade dynamics. This volatile commercial landscape complicates supply network planning and prevents manufacturers from maintaining the consistent output levels required to support the market's steady development.

Key Market Trends

The skinification of hair and scalp care formulations represents a transformative shift where scalp health is treated with the same rigor as facial skin, directly expanding the application scope of niacinamide. This trend drives the inclusion of the ingredient in premium shampoos and scalp serums, leveraging its capacity to enhance keratin synthesis and fortify the lipid barrier against environmental stressors. Manufacturers are increasingly highlighting these clinical benefits to address inflammation and moisture retention at the root, thereby creating a new high-value category for Vitamin B3 consumption. This strategic focus on scalp-centric innovation is generating measurable commercial success for major personal care conglomerates. According to Unilever, February 2024, in the 'Full Year 2023 Results', their Clear brand delivered mid-single digit growth, driven specifically by a new clinically proven anti-dandruff formula powered by a niacinamide concentrate designed to repair the scalp’s skin barrier.

Concurrently, the integration of niacinamide into men’s minimalist grooming lines is widening the market among consumers seeking efficient, multi-functional products. Formulations in this segment now prioritize versatile active ingredients that address excess sebum, pore size, and post-shave irritation within simplified regimens. Niacinamide’s anti-inflammatory and oil-regulating properties make it an ideal cornerstone for these hybrid products, fueling the sector's expansion beyond traditional shaving foams into comprehensive skin health solutions. This demand for advanced grooming innovation is reflected in the recent financial performance of key market leaders. According to Procter & Gamble, August 2024, in the '2024 Annual Report', the company's Grooming segment achieved a net sales increase of 7% versus the prior year, underscoring the growing consumer appetite for premium, innovation-driven daily care products that utilize such multifunctional actives.

Segmental Insights

The liquid form is identified as the fastest-growing segment in the global niacinamide market, driven largely by its operational advantages in the animal feed and pharmaceutical sectors. This growth is attributed to the high solubility of liquid niacinamide, which facilitates seamless integration into liquid feed additives and automated dosing systems, ensuring uniform nutrient distribution. Additionally, the pharmaceutical and cosmetic industries increasingly utilize liquid variants for simplified formulation in serums and syrups. This trend aligns with stringent solubility and stability requirements outlined by regulatory frameworks such as those maintained by the United States Food and Drug Administration.

Regional Insights

North America maintains a leading position in the global niacinamide market due to extensive application across the pharmaceutical, cosmetic, and animal nutrition sectors. The region benefits from high consumer awareness regarding skin health and dietary wellness, prompting increased adoption of vitamin B3 products. Regulatory clarity provided by the United States Food and Drug Administration, which classifies niacinamide as generally recognized as safe, further encourages its utilization in supplements and fortified foods. This favorable regulatory environment, combined with established manufacturing infrastructure, sustains the region's dominance by ensuring consistent supply to meet industrial requirements.

Recent Developments

  • In September 2024, the science-based ingredient supplier DSM-Firmenich presented new research showcasing a skincare solution that combines its specialized Niacinamide PC with a postbiotic ingredient known as OXY 229 CB. During the presentation, the company highlighted data demonstrating that this specific combination significantly outperforms traditional brightening agents, such as Vitamin C, in improving skin radiance and reducing hyperpigmentation. The development was marketed to formulators as a stable and high-performance alternative for creating products that energize the skin and promote cell turnover.
  • In August 2024, The Ordinary expanded its portfolio beyond facial skincare by entering the body care category with the launch of its Niacinamide 5% Face and Body Emulsion. This new product was designed to address uneven skin tone and texture on the body, treating areas often prone to dark spots such as the neck, chest, and arms. The formulation utilizes a lower concentration of niacinamide compared to the brand's popular face serum to ensure suitability for sensitive skin while strengthening the skin barrier and delivering hydration.
  • In April 2024, La Roche-Posay, a division of the L'Oréal Group, launched the Mela B3 Dark Spot Serum and Mela B3 UV Daily Moisturizer in the United States, targeting skin discoloration and pigmentation disorders. These products feature a new multi-patented molecule called Melasyl, which was developed over 18 years of research, combined with a 10% concentration of niacinamide. The company stated that this synergistic formulation works to intercept excess melanin production before it marks the skin, offering a comprehensive solution for age spots, sun spots, and post-acne marks across all skin tones.
  • In February 2024, the skincare brand Pond's, owned by Unilever, introduced a new proprietary ingredient complex named Niasorcinol as part of its "Bright Miracle" product range launch. This innovation combines niacinamide with ethyl resorcinol, a formulation the company claims was developed to enhance the skin brightening and spot-reducing efficacy of traditional niacinamide. The brand positioned this launch as a significant advancement in addressing hyperpigmentation and dullness, stating that the Niasorcinol complex penetrates deep into the skin to boost autophagy and improve skin clarity more effectively than basic brightening actives.

Key Market Players

  • BASF
  • Lonza
  • Ashland
  • Shandong Xinchang
  • Jubilant Ingrevia
  • DSM
  • Hebei Welcome
  • Zhejiang Medicine
  • Evonik Industries
  • Foodchem International Corporation

By Type

By End User

By Region

  • Powder
  • Liquid
  • Others
  • Human Nutrition
  • Pharmaceuticals
  • Animal Nutrition
  • Cosmeceuticals
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Niacinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Niacinamide Market, By Type:
  • Powder
  • Liquid
  • Others
  • Niacinamide Market, By End User:
  • Human Nutrition
  • Pharmaceuticals
  • Animal Nutrition
  • Cosmeceuticals
  • Others
  • Niacinamide Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Niacinamide Market.

Available Customizations:

Global Niacinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Niacinamide Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Niacinamide Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Type (Powder, Liquid, Others)

5.2.2.  By End User (Human Nutrition, Pharmaceuticals, Animal Nutrition, Cosmeceuticals, Others)

5.2.3.  By Region

5.2.4.  By Company (2025)

5.3.  Market Map

6.    North America Niacinamide Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Type

6.2.2.  By End User

6.2.3.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Niacinamide Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Type

6.3.1.2.2.  By End User

6.3.2.    Canada Niacinamide Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Type

6.3.2.2.2.  By End User

6.3.3.    Mexico Niacinamide Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Type

6.3.3.2.2.  By End User

7.    Europe Niacinamide Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Type

7.2.2.  By End User

7.2.3.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Niacinamide Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Type

7.3.1.2.2.  By End User

7.3.2.    France Niacinamide Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Type

7.3.2.2.2.  By End User

7.3.3.    United Kingdom Niacinamide Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Type

7.3.3.2.2.  By End User

7.3.4.    Italy Niacinamide Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Type

7.3.4.2.2.  By End User

7.3.5.    Spain Niacinamide Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Type

7.3.5.2.2.  By End User

8.    Asia Pacific Niacinamide Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Type

8.2.2.  By End User

8.2.3.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Niacinamide Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Type

8.3.1.2.2.  By End User

8.3.2.    India Niacinamide Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Type

8.3.2.2.2.  By End User

8.3.3.    Japan Niacinamide Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Type

8.3.3.2.2.  By End User

8.3.4.    South Korea Niacinamide Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Type

8.3.4.2.2.  By End User

8.3.5.    Australia Niacinamide Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Type

8.3.5.2.2.  By End User

9.    Middle East & Africa Niacinamide Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Type

9.2.2.  By End User

9.2.3.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Niacinamide Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Type

9.3.1.2.2.  By End User

9.3.2.    UAE Niacinamide Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Type

9.3.2.2.2.  By End User

9.3.3.    South Africa Niacinamide Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Type

9.3.3.2.2.  By End User

10.    South America Niacinamide Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Type

10.2.2.  By End User

10.2.3.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Niacinamide Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Type

10.3.1.2.2.  By End User

10.3.2.    Colombia Niacinamide Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Type

10.3.2.2.2.  By End User

10.3.3.    Argentina Niacinamide Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Type

10.3.3.2.2.  By End User

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Niacinamide Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  BASF

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Lonza

15.3.  Ashland

15.4.  Shandong Xinchang

15.5.  Jubilant Ingrevia

15.6.  DSM

15.7.  Hebei Welcome

15.8.  Zhejiang Medicine

15.9.  Evonik Industries

15.10.  Foodchem International Corporation

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Niacinamide Market was estimated to be USD 715.23 Million in 2025.

North America is the dominating region in the Global Niacinamide Market.

Liquid segment is the fastest growing segment in the Global Niacinamide Market.

The Global Niacinamide Market is expected to grow at 4.75% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.